Memory and the septo-hippocampal system DOI
Neil McNaughton,

Jeffrey A. Gray

Oxford University Press eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 189 - 240

Published: May 7, 2024

Abstract ‘Memory and the septo-hippocampal system’ outlines five major myths about amnesia that have dogged analysis of function it critiques 10 theories ‘type’ memory supported by hippocampus: spatial, working, configural, recognition, semantic, contextual, relational, temporal buffer, intermediate, multiple trace transformation, contextual binding. In all cases there are non-conforming data and, in bulk cases, one can discern a role for interference. The suggest rather than amnesia, hippocampal damage produces catastrophic hypermnesia due to loss mechanism reverse effects interference once these occurred. This mechanism, Goal Inhibition System, not only accounts failure but also non-memorial changes result from damage. relation key aspects is outlined; hippocampus formation, consolidation, retrograde activation considered both wake sleep.

Language: Английский

The Neuropsychology of Anxiety DOI
Neil McNaughton,

Jeffrey A. Gray

Oxford University Press eBooks, Journal Year: 2024, Volume and Issue: unknown

Published: May 7, 2024

Abstract The Neuropsychology of Anxiety first appeared in 1982 as the volume Oxford Psychology Series, and it quickly established itself classic work on subject. It second edition (appearing 2000) have been cited at a steadily increasing rate passing 500/year 2017. field has continued to expand last quarter century necessitating this third edition. This completely updated revised (with many figures converted colour) retains original core concepts while expanding often simplifying details. includes new chapter prefrontal cortex, which integrates frontal hippocampal views anxiety an extensively modified personality providing basis for further developments Reinforcement Sensitivity Theory. book is essential postgraduate students researchers experimental psychology neuroscience, well all clinical psychologists psychiatrists.

Language: Английский

Citations

73

Sigma-1 Receptor Specific Biological Functions, Protective Role, and Therapeutic Potential in Cardiovascular Diseases DOI
Ahmed Al‐Maamari,

Marwa Sultan,

Tao Zhang

et al.

Cardiovascular Toxicology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 12, 2025

Language: Английский

Citations

1

The Sigma Receptors in Alzheimer’s Disease: New Potential Targets for Diagnosis and Therapy DOI Open Access
Tao Wang, Hongmei Jia

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(15), P. 12025 - 12025

Published: July 27, 2023

Sigma (σ) receptors are a class of unique proteins with two subtypes: the sigma-1 (σ1) receptor which is situated at mitochondria-associated endoplasmic reticulum (ER) membrane (MAM), and sigma-2 (σ2) receptor, located in ER-resident membrane. Increasing evidence indicates involvement both σ1 σ2 pathogenesis Alzheimer’s disease (AD), thus these represent potentially effective biomarkers for emerging AD therapies. The availability optimal radioligands positron emission tomography (PET) neuroimaging humans will provide tools to monitor progression treatment outcomes. In this review, we first summarize significance pathophysiology highlight therapeutic strategies related receptors. We then survey potential PET radioligands, an emphasis on requirements imaging or humans. Finally, discuss current challenges development receptors, opportunities elucidate as novel early diagnosis, monitoring drug efficacy.

Language: Английский

Citations

15

The New Version of the ANDDigest Tool with Improved AI-Based Short Names Recognition DOI Open Access
Timofey Ivanisenko, П. С. Деменков, Н. А. Колчанов

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(23), P. 14934 - 14934

Published: Nov. 29, 2022

The body of scientific literature continues to grow annually. Over 1.5 million abstracts biomedical publications were added the PubMed database in 2021. Therefore, developing cognitive systems that provide a specialized search for information based on subject area ontology and modern artificial intelligence methods is urgently needed. We previously developed web-based retrieval system, ANDDigest, designed analyze using customized domain ontology. This paper presents an improved ANDDigest version uses fine-tuned PubMedBERT classifiers enhance quality short name recognition molecular-genetics entities eight biological object types: cell components, diseases, side effects, genes, proteins, pathways, drugs, metabolites. approach increased average accuracy by 13%.

Language: Английский

Citations

19

Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels DOI
Hui Ma, Jinfeng Li,

Xin Qiao

et al.

Acta Pharmacologica Sinica, Journal Year: 2023, Volume and Issue: 45(4), P. 704 - 713

Published: Dec. 14, 2023

Language: Английский

Citations

12

Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors DOI Creative Commons
Tao Wang, Na Sun, Yuefeng Ma

et al.

ACS Pharmacology & Translational Science, Journal Year: 2025, Volume and Issue: 8(4), P. 951 - 977

Published: March 7, 2025

Cancer ranks among the top triumvirate leading causes of human deaths worldwide. The pathological mechanisms are notably intricate, demonstrating proliferative and metastatic capabilities, which complicate therapeutic interventions. sigma-1 receptor (σ1R) plays a crucial role in tumor survival migration, while sigma-2 (σ2R) is intimately associated with proliferation. This review encapsulated investigation concerning σ1R σ2R neoplasms rigorously summarized ligands radio-ligands development their applications, such as antitumor cell proliferation PET/SPECT imaging tumors. A comprehensive classification discussion was undertaken regarding chemical structures emphasized possibility dual/multitargeted ligands. Ultimately, we discussed effects chiral pharmacological characteristics on affinity pharmacokinetic features vivo, particularly radiopharmaceuticals. functions beneficial resource, fostering ligand deployment stimulating generation innovative ideas for developing

Language: Английский

Citations

0

Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression DOI

Chung‐Feng Kao,

Shih‐Jen Tsai,

Tung‐Ping Su

et al.

Journal of Psychopharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: March 24, 2025

Background: Low-dose ketamine is an N-methyl-D-aspartate receptor antagonist that exerts antidepressant effect on patients with treatment-resistant depression (TRD). This may extend beyond the glutamatergic hypothesis. Nevertheless, roles of genes encoding other monoamine neurotransmitters (i.e., serotonin and dopamine) in neuromechanism low-dose remain unknown. Methods: In this clinical trial, which involved 65 TRD, 21 received 0.5 mg/kg ketamine, 20 0.2 24 normal saline. All were genotyped for 684,616 single-nucleotide polymorphisms (SNPs). A total 50 neurotransmitter-related candidate genes, including HTR2A HTR2C from serotoninergic system, CHRM4 CHRNB1 cholinergic DRD2 dopaminergic selected to conduct a gene-based genome-wide association study effects ketamine. Results: Gene-set enrichment analysis revealed pathway underlying neuroactive ligand–receptor interaction (KEGG) played pivotal role biomechanisms ketamine’s effect. Specifically, SNPs related system (e.g., rs2644247 CHRM5), μ1 opioid rs2473546 OPRM1), rs2617577 SLC6A3), serotonergic (HTR2A), cannabinoid (CNR2), σ1 (SIGMAR1) associated Discussion: has effect, be multiple neurotransmitter systems receptor.

Language: Английский

Citations

0

Sigma-1 Receptor Rescues Autophagy Through AMPK/mTOR Signaling Pathway in Sepsis-Induced Acute Kidney Injury DOI Creative Commons
Wei Jiang, Jianfeng Zhang, Yinan Zhang

et al.

International Journal of General Medicine, Journal Year: 2025, Volume and Issue: Volume 18, P. 1917 - 1931

Published: April 1, 2025

This study aimed to investigate the effects of σ-1R on autophagy in sepsis-AKI and its potential involvement AMPK/mTOR signaling pathway. The serum samples from patients were used diagnose sepsis using double-blind randomized method quantify inflammatory cytokines enzyme-linked immunosorbent assays. HK-2 cells induced by lipopolysaccharide (LPS) employed as an vitro model sepsis-AKI. To evaluate function sepsis-AKI, siRNA overexpression plasmid targeting used. marker expressions analyzed quantitative real-time polymerase chain reaction Western blot Cell proliferation was evaluated CCK-8 EdU assays, cell apoptosis detected flow cytometry TUNEL staining Phosphorylated proteins In levels reduced, whereas interleukin-1β (IL-1β), IL-6, tumor necrosis factor-α (TNF-α) increased. promoted LPS-induced while inhibiting apoptosis. Moreover, enhanced autophagy, evidenced upregulation biomarkers LC3-II/LC3-I Beclin 1. Furthermore, phosphorylation AMPK ULK1 mTOR. utilizes pathway enhance indicating that may serve a promising target for diagnosis therapy.

Language: Английский

Citations

0

The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressants DOI
Nan Xiao,

Liyang Yin,

Kayla M. Teopiz

et al.

Expert Opinion on Therapeutic Targets, Journal Year: 2025, Volume and Issue: unknown

Published: April 29, 2025

The mechanism of action antidepressants is not fully ascertained. In addition to monoamines, disparate other effectors are also implicated in the molecular and cellular effects chronic stress including neurogenesis, neurodifferentiation, neuroplasticity. Evidence suggests sigma-1 receptors (S1R) as a putative target possible mediator antidepressant activity. Data from preclinical clinical trials was synthesized inception August 2024. Results showed that S1R regulate neurotransmitter availability release (e.g. glutamate), influence intracellular Ca2+ levels well immune inflammatory responses. introduction N-Methyl-D-aspartic Acid (NMDA) antagonist/S1R agonist dextromethorphan-bupropion 2022 represented first time Food Drug Administration (FDA) permitted language hypothesized an involved activity at S1R. We describe physiology, pathophysiology, function Sigma-1 modulation relevant agents currently FDA-approved major depressive disorder (MDD) (dextromethorphan-bupropion). Modulating systems fit for purpose it relates future therapeutic discoveries development mental disorders. Whether uniquely targeting dimensions psychopathology more difficult treat (i.e. anhedonia) awaits determination.

Language: Английский

Citations

0

Anxiety and personality DOI
Neil McNaughton,

Jeffrey A. Gray

Oxford University Press eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 371 - 430

Published: May 7, 2024

Abstract ‘Anxiety and personality’ links the anxiolytic-derived state neuropsychology of previous chapters to personality traits. Traits are seen as sensitivities structures, goal control systems, more global modulators systems. It lays ground work for seeing psychiatric disorders resulting from one or extreme sensitivities. While main focus is anxiety, it also discusses implications Reinforcement Sensitivity Theory (RST) with additional comment on Big 5. reviews issues arising word meanings, evolution, need biomarkers, hierarchical organization, continuity versus discontinuity provides recommendation application work, throughout. distinguishes neuroticism trait a new dopaminergic neurology reinforcement sensitivity, strongly reinforcers, first anxiety disorder biomarker, identifies problems existing RST scales, future neural solutions.

Language: Английский

Citations

2